Skip to main content
Caplight Logo









Universal Stabilization Technologies

Universal Stabilization Technologies

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.vitrilife.com/

Last Round

Grant

Jun 23, 2021

Total Funding Raised

$2.5M

Company Overview

Universal Stabilization Technologies is a biopharmaceutical R&D company that provides stabilization and delivery enabling technologies for vaccines and biologics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

thermostabilizationcold chain logisticsvitrificationbiologic stabilizationvaccine storageambient temperature storagedrug delivery systemsfoam-dryingpreservation by vaporizationPBVbiotech R&Dcold chain freeshelf-stable biologicsformulation developmentdrug stability

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Universal Stabilization Technologies Comparables

Compare Universal Stabilization Technologies with similar companies based on industry and business-model similarity.

Universal Stabilization Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elarex Inc.
87%
Inaedis Inc.
85%
Stablepharma
82%

Universal Stabilization Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 23, 2021
GrantJul 27, 2018
GrantFeb 10, 2015

Universal Stabilization Technologies Investors

Notable investors and investment history

Universal Stabilization Technologies investors
InvestorRounds
National Institute of Allergy and Infectious DiseasesGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2021

    $596K grant received from National Institute of Allergy and Infectious Diseases.

  • Jul 27, 2018

    $600K grant from National Institute of Allergy and Infectious Diseases.

Universal Stabilization Technologies Filings

Explore SEC and related filing metadata, where available.

Universal Stabilization Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Universal Stabilization Technologies's valuation, stock price, and market status.

Is Universal Stabilization Technologies a public or private company?

Universal Stabilization Technologies is a private company.

What is the current stock price of Universal Stabilization Technologies?

Universal Stabilization Technologies is a private company with no public stock price. Caplight tracks Universal Stabilization Technologies's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Universal Stabilization Technologies worth (valuation)?

Valuation information for Universal Stabilization Technologies is not publicly available.

Can I buy Universal Stabilization Technologies stock?

Universal Stabilization Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Universal Stabilization Technologies's last funding round?

Universal Stabilization Technologies's most recent funding round was Grant on June 23, 2021.

Who are the main investors in Universal Stabilization Technologies?

Key investors in Universal Stabilization Technologies include National Institute of Allergy and Infectious Diseases.

Will Universal Stabilization Technologies IPO soon?

No public IPO plans have been announced for Universal Stabilization Technologies.

How can I track Universal Stabilization Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Universal Stabilization Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range3
Year Founded2002
Last FundingJun 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?